Skip to main content
U.S. flag

An official website of the United States government

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

32 results
  1. ... GRADE evidence profile: What are the most effective adjuvant intravesical therapy (chemotherapy or immunotherapy) ... Table 33 GRADE evidence profile: What ...
  2. ... or 4 worst overall toxicities H.14.10. Adjuvant immunotherapy versus no adjuvant therapy in resected pancreatic cancer patients Figure 406 ...
  3. ... n=61) showed no clinically important difference between adjuvant immunotherapy (MoAb 494/32) and no adjuvant therapy on ... n=61) showed no clinically important difference between adjuvant immunotherapy (MoAb 494/32) and no adjuvant therapy on ...
  4. ... relevant to PICO. Davar D, Tarhini, et al. Adjuvant immunotherapy of melanoma and development of new approaches using ...
  5. ... for the StatRoc study (A Feasibility Study of Adjuvant Statin Therapy in the Prevention of Post-Operative Recurrence of Oesophageal Adenocarcinoma). Funded by NIHR. No ...
  6. ... Goodwin A, Parker S, Ghersi D, et al.: Post-operative radiotherapy for ductal carcinoma ... National Surgical Adjuvant Breast Project (NSABP) B-17 Trial. Unanswered questions ...
  7. ... or double intravesical epirubicin instillation in the early postoperative period to prevent ... A, et al. Adjuvant chemotherapy with early intravesical instillation of adriamycin and ...
  8. NLM Digital Collections - National Library of Medicine classification : a scheme for the shelf arrangement of library ... 
    Publication: Bethesda, Md. : U.S. Dept. of Health and Human Services, Public Health Service, National Institutes of Health, National Library of Medicine ; Washington, D.C. : For sale by the Supt. of Docs., U.S. G.P.O., 1994
    ... In antigen-antibody complex QW 570 Immunostimulants see Adjuvants, Immunologic ... Immunologic Immunotherapy QW 940-949 Of a particular disease, with ...
  9. ... In antigen-antibody complex QW 570 Immunostimulants see Adjuvants, Immunologic ... Immunologic Immunotherapy QW 940-949 Of a particular disease, with ...
  10. ... Adoptive Transfer E05.478.550.520.050.400 Immunotherapy, Adoptive E05.478.550.545 Immunization Schedule E05. ... 550.550 Immunization, Secondary E05.478.550.600 Immunotherapy, Active E05.478.550.600.890 Vaccination E05. ...
previous · 1 · 2 · 3 · next